Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Vera Therapeutics (VERA) SEC Filings & 10K Form

Vera Therapeutics logo
$22.29 +0.27 (+1.23%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$22.28 -0.01 (-0.04%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Vera Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
10:00 AM		Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G
08/05/2025
3:53 PM		Vera Therapeutics (Filer)
Form 424B5
08/05/2025
6:30 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
7:07 PM		ENRIGHT PATRICK G (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:38 PM		Flynn James E (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G
06/03/2025
5:36 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
5:36 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:00 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
3:44 PM		Vera Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:21 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
7:00 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:05 PM		JOHNSON DAVID LEE (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:07 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:08 PM		Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:10 PM		Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:30 AM		Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:06 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:22 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:24 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:59 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
3:05 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:40 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
11:15 AM		Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:35 AM		Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G
11/12/2024
9:34 AM		FMR LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/07/2024
7:00 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
6:49 PM		Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
10/31/2024
5:05 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:15 PM		Vera Therapeutics (Filer)
Form 424B5
10/29/2024
5:15 AM		Vera Therapeutics (Filer)
Form 424B5
10/28/2024
4:29 PM		Vera Therapeutics (Filer)
Form S-3ASR
10/28/2024
4:30 PM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:37 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:16 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:05 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:17 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
8:01 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:05 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:45 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:38 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:38 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
09/13/2024
3:36 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:19 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:04 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VERA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel